RankingsPricing
  1. JP-listed companies
  2. SANTEN PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Diluted EPS

SANTEN PHARMACEUTICAL CO.,LTD.【JP:4536】

Market cap
¥595B
P/E ratio
16.9x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndDiluted EPS (JPY)YoY (%)
Mar 31, 202550.9+0.30%
Mar 31, 202450.7-231.45%
Mar 31, 2023-38.6-188.67%
Mar 31, 202243.5-19.88%
Mar 31, 202154.3-20.64%
Mar 31, 202068.5-0.44%
Mar 31, 201968.8+10.26%
Mar 31, 201862.4+2.73%
Mar 31, 201760.7-50.97%
Mar 31, 2016123.8+127.51%
Mar 31, 201554.4+31.65%
Mar 31, 201441.3-78.86%
Mar 31, 2013195.5-0.64%
Mar 31, 2012196.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)